As contact lens fitters, too often we find ourselves fixated over obtaining the very best visual results for our patients. These days we can specify a dizzying array of toric powers and axes into our soft daily lenses. We can incorporate spherical aberration correction and multifocal optics into our
The recently published TFOS DEWS II report was more than two years in the making. Key to bringing it to fruition was Auckland University-based Associate Professor Jennifer Craig, vice chair of the
Interestingly pain perceived as ocular surface pain, can differ in origin. Nociceptive pain (caused by a corneal abrasion for example) is the normal activation of the cornea’s nociceptors. The
Research in dry eye disease has gained momentum – in part due to the recent publication of the Tear Film and Ocular Surface Dry Eye Workshop II (TFOS DEWSII) report, a culmination of more than two
After almost two and a half years of work, the near 400-page TFOS DEWS II report has been published by the Tear Film & Ocular Surface Society (TFOS). This massive undertaking involved 150 researchers
Emerging from the buzz of TFOS DEWS II, I’m getting my first chance to step back and take stock of the work that 150 experts in the field have contributed, pro bono, to reach consensus on many aspects
In conjunction with the University of Auckland’s Ocular Surface team, led by Associate Professor Jennifer Craig, and their international collaborators, dry eye is being investigated as part of the
Infestation of the eyelash follicles and meibomian glands with Demodex mites is emerging as a significant cause of blepharitis. This article reviews key aspects of Demodex biology and pathogenesis, as
For many years, blepharitis and dry eye disease (DED) have been thought to be two distinct diseases, and evaporative dry eye distinct from aqueous insufficiency. Consider the "Chicken-and-egg", a
Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases; A randomized, double masked, placebo-controlled clinical trial of two forms of Omega-3 supplements for treating dry eye disease; Outcomes and complicati